JOURNAL OF DRUGS IN DERMATOLOGY, cilt.10, sa.4, ss.403-408, 2011 (SCI-Expanded)
Objective: Long-term survival for advanced stages of mycosis fungoides (ME) may be beneficially affected by the use of multimodality therapy. We aim to evaluate the activity of vorinostat in combination with interferon (IFN) alpha and extracorporeal photopheresis (ECP) with persistent, progressive advanced stage MF and Sezary syndrome (SS).